Analyst picks & changes

U.S. Bioscience Inc.

(UBS), West Conshohocken, Penn.

Business: Cancer

Montgomery Securities analyst David Crossen began coverage with a "buy"

Read the full 197 word article

How to gain access

Continue reading with a
two-week free trial.